PRODUCTS AND R&D
PRODUCTION BASES
Luzhu Biotech has a pilot and scale-up workshop meeting GMP requirements in Beijing and two production sites: Zhuhai Site I and Zhuhai Site II.
PRESS CENTER
2022-04-19
Luzhu Biotech entered a licensing agreement to use Lonza’s GS Xceed® Gene Expression System with GS piggyBac® transposon technology....
2021-08-30
Luzhu Biotech completed Series B financing of CNY 350 million
On August 30, 2021, Beijing Luzhu Biotechnology Co., Ltd. announced the completion of Series B financing of CNY 350 million....
2021-08-03
Luzhu Biotech obtained clinical trial approval for "Recombinant Herpes Zoster Vaccine (CHO cells)"
On August 3, 2021, Luzhu Biotech obtained clinical trial approval letter for "Recombinant Herpes Zoster Vaccine (CHO cells)" (Approval number: 2021LP01212)....